|
1
|
Rose L: Financial incentives for At-home
colorectal cancer screening tests. JAMA Netw Open. 2:e1911682019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dang YZ, Li P, Li JP, Zhang Y, Zhao LN, Li
WW, Wei LC and Shi M: Efficacy and toxicity of IMRT-based
simultaneous integrated boost for the definitive management of
positive Lymph nodes in patients with cervical cancer. J Cancer.
10:1103–1109. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee YH, Kung PT, Wang YH, Kuo WY, Kao SL
and Tsai WC: Effect of length of time from diagnosis to treatment
on colorectal cancer survival: A population-based study. PLoS One.
14:e02104652019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deng J, Cui J, Jiang N, Zhang R, Zhang L,
Hao X and Liang H: STAT3 regulation the expression of VEGF-D in
HGC-27 gastric cancer cell. Am J Transl Res. 6:756–767.
2014.PubMed/NCBI
|
|
7
|
Chen C, He W, Huang J, Wang B, Li H, Cai
Q, Su F, Bi J, Liu H, Zhang B, et al: LNMAT1 promotes lymphatic
metastasis of bladder cancer via CCL2 dependent macrophage
recruitment. Nat Commun. 9:38262018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim HJ, Jo MJ, Kim BR, Kim JL, Jeong YA,
Na YJ, Park SH, Lee SY, Lee DH, Kim BH, et al: Overexpression of
Romo1 is an unfavorable prognostic biomarker and a predictor of
lymphatic metastasis in non-small cell lung cancer patients.
OncoTargets Ther. 11:4233–4246. 2018. View Article : Google Scholar
|
|
9
|
Zheng Y, Song D, Xiao K, Yang C, Ding Y,
Deng W and Tong S: LncRNA GAS5 contributes to lymphatic metastasis
in colorectal cancer. Oncotarget. 7:83727–83734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin J, Feng J, Jin Y, Yan Z, Lai Z and
Peng J: Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis
in colorectal cancer. Oncol Rep. 6:3568–3576. 2016. View Article : Google Scholar
|
|
11
|
Podemska-Jedrzejczak Z, Malinska A,
Sujka-Kordowska P, Nowicki M, Puslecki M, Jemielity M and Perek B:
Vascular restenosis in coronary artery bypass grafting might be
associated with VEGF-C/VEGFR-3 signaling pathway. Heart Vessels.
33:1106–1120. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li C, Zhu M, Lou X, Liu C, Chen H, Lin X,
Ji W, Li Z and Su C: Transcriptional factor OCT4 promotes
esophageal cancer metastasis by inducing epithelial-mesenchymal
transition through VEGF-C/VEGFR-3 signaling pathway. Oncotarget.
8:71933–71945. 2017.PubMed/NCBI
|
|
13
|
Liu ZY, Qiu HO, Yuan XJ, Ni YY, Sun JJ,
Jing W and Fan YZ: Suppression of lymphangiogenesis in human
lymphatic endothelial cells by simultaneously blocking VEGF-C and
VEGF-D/VEGFR-3 with norcantharidin. Int J Oncol. 41:1762–1772.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng H, Zhou T, Mo X, Liu C and Yin Y:
Low-density lipoprotein promotes lymphatic metastasis of esophageal
squamous cell carcinoma and is an adverse prognostic factor. Oncol
Lett. 17:1053–1061. 2019.PubMed/NCBI
|
|
15
|
Dai Y, Tong R, Guo H, Yu T and Wang C:
Association of CXCR4, CCR7, VEGF-C and VEGF-D expression with lymph
node metastasis in patients with cervical cancer. Eur J Obstet
Gynecol Reprod Biol. 214:178–183. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Wu J, Zhang D, Wang K, Duan X and
Zhang X: A network pharmacology approach to uncover the multiple
mechanisms of Hedyotis diffusa Willd. on colorectal cancer.
Evid Based Complement Alternat Med. 2018:65170342018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang C, Zhou X, Wang Y, Wei D, Deng C, Xu
X, Xin P and Sun S: the antitumor constituents from Hedyotis
diffusa Willd. Molecules. 22:E21012017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen WJ, Jin YY, Yang H, Wei LH and Lin
JM: Hedyotis diffusa Willd reduces migration and invasion
through inhibition of TGF-β-induced EMT in colorectal cancer cells.
Eur J Intre Med. 23:57–63. 2018. View Article : Google Scholar
|
|
19
|
Li Q, Lai Z, Yan Z, Peng J, Jin Y, Wei L
and Lin J: Hedyotis diffusa Willd inhibits proliferation and
induces apoptosis of 5-FU resistant colorectal cancer cells by
regulating the PI3K/AKT signaling pathway. Mol Med Rep. 17:358–365.
2018.PubMed/NCBI
|
|
20
|
Yan Z, Feng J, Peng J, Lai Z, Zhang L, Jin
Y, Yang H, Chen W and Lin J: Chloroform extract of Hedyotis
diffusa Willd inhibits viability of human colorectal cancer
cells via suppression of AKT and ERK signaling pathways. Oncol
Lett. 14:7923–7930. 2017.PubMed/NCBI
|
|
21
|
Lai Z, Yan Z, Chen W, Peng J, Feng J, Li
Q, Jin Y and Lin J: Hedyotis diffusa Willd suppresses
metastasis in 5-fluorouracil-resistant colorectal cancer cells by
regulating the TGF-β signaling pathway. Mol Med Rep. 16:7752–7758.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng J, Jin Y, Peng J, Wei L, Cai Q, Yan
Z, Lai Z and Lin J: Hedyotis diffusa willd extract
suppresses colorectal cancer growth through multiple cellular
pathways. Oncol Lett. 14:8197–8205. 2017.PubMed/NCBI
|
|
23
|
Li Y, Wang X, Wang X, Wan L, Liu Y, Shi Y,
Zhang L, Fang Z and Wei Z: PDCD4 suppresses proliferation,
migration, and invasion of endometrial cells by inhibiting
autophagy and NF-κB/MMP2/MMP9 signal pathway. Biol Reprod.
99:360–372. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao L, Liu Y, Wang D, Huang L, Li F, Liu
J, Zhang C, Shen Z, Gao Q, Yuan W and Zhang Y: MiR-760 suppresses
human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1
signaling. J Exp Clin Cancer Res. 37:832018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kodera Y, Katanasaka Y, Kitamura Y, Tsuda
H, Nishio K, Tamura T and Koizumi F: Sunitinib inhibits lymphatic
endothelial cell functions and lymph node metastasis in a breast
cancer model through inhibition of vascular endothelial growth
factor receptor 3. Breast Cancer Res. 13:R662011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sammarco G, Varricchi G, Ferraro V,
Ammendola M, De Fazio M, Altomare DF, Luposella M, Maltese L, Currò
G, Marone G, et al: Mast cells, angiogenesis and lymphangiogenesis
in human gastric cancer. Int J Mol Sci. 9:E21062019. View Article : Google Scholar
|
|
27
|
Huang C and Chen Y: Lymphangiogenesis and
colorectal cancer. Saudi Med J. 38:237–244. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Huang Y, Zhang J, Wei Y, Mahoud S,
Bakheet AM, Wang L, Zhou S and Tang J: Pathway-related molecules of
VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic
metastasis. Clin Chim Acta. 461:165–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tao P, Wen H, Yang B, Zhang A, Wu X and Li
Q: miR-144 inhibits growth and metastasis of cervical cancer cells
by targeting VEGFA and VEGFC. Exp Ther Med. 15:562–568.
2018.PubMed/NCBI
|
|
30
|
Lin J, Wei L, Shen A, Cai Q, Xu W, Li H,
Zhan Y, Hong Z and Peng J: Hedyotis diffusa Willd extract
suppresses Sonic hedgehog signaling leading to the inhibition of
colorectal cancer angiogenesis. Int J Oncol. 42:651–656. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Tang H, Zhang YM and Zhang TL:
Toxicological safety of Hedyotis diffusa. J Toxicol.
28:249–252. 2014.(In Chinese).
|
|
32
|
Naim A, Pan Q and Baig MS: Matrix
metalloproteinases (MMPs) in liver diseases. J Clin Exp Hepatol.
7:367–372. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jing ZT, Liu W, Wu SX, He Y, Lin YT, Chen
WN, Lin XJ and Lin X: Hepatitis B virus surface antigen enhances
the sensitivity of hepatocytes to Fas-mediated apoptosis via
suppression of AKT phosphorylation. J Immunol. 201:2303–2314. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiang L, Xie G, Ou J, Wei X, Pan F and
Liang H: The extra domain A of fibronectin increases VEGF-C
expression in colorectal carcinoma involving the PI3K/AKT signaling
pathway. PLoS One. 7:e353782012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu C, Qi X, Chen Y, Sun B, Dai Y and Gu
Y: PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in
IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res
Clin Oncol. 137:1587–1594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Peng X, Wang Z, Liu Y, Peng X, Liu Y, Zhu
S, Zhang Z, Qiu Y, Jin M, Wang R, et al: Oxyfadichalcone C inhibits
melanoma A375 cell proliferation and metastasis via suppressing
PI3K/Akt and MAPK/ERK pathways. Life Sci. 206:35–44. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou S and Sakamoto K: Pyruvic acid/ethyl
pyruvate inhibits melanogenesis in B16F10 melanoma cells through
PI3K/AKT, GSK3β, and ROS-ERK signaling pathways. Genes Cells.
24:60–69. 2019. View Article : Google Scholar : PubMed/NCBI
|
